2-(Morpholin-4-ylmethyl)aniline
CAS: 95539-61-0
Ref. 3D-FM51039
| 1g | Descontinuado | ||
| 2g | Descontinuado | ||
| 5g | Descontinuado | ||
| 10g | Descontinuado |
Informação sobre produto
Nome:
2-(Morpholin-4-ylmethyl)aniline
Sinónimos:
- 2-(4-Morpholinylmethyl)phenylamine
- Benzenamine, 2-(4-Morpholinylmethyl)-
- 2-(Morpholinomethyl)aniline
Descrição:
2-(Morpholin-4-ylmethyl)aniline (EMMA) is a drug that inhibits the growth of leukaemia cells by binding to their receptor tyrosine. It blocks the cycle of cell proliferation, triggering apoptosis and inhibiting signalling pathways. EMMA has been shown to be effective in animal models against many types of cancer and has nanomolar potency. EMMA binds to the ATP-binding site on the receptor tyrosine kinase, preventing it from activating other proteins that are involved in cell signalling. This prevents the activation of proteins that stimulate cell proliferation and eosinophilic differentiation, which is important for suppressing leukaemia cell growth. EMMA also targets leukaemia cells at G1 phase by interfering with protein synthesis.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
192.26 g/mol
Fórmula:
C11H16N2O
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
